An earlier study by Li et al. suggested a relation between GLI1 and MGMT expression in promoting GBM cells’ therapeutic resistance, and the inhibition of GLI1 with GANT61 reduced MGMT levels and increased TMZ-induced DNA DSBs [73]. This evidence concerns the gene GLI1 and glioblastoma.